Pricing and Market Access of ATMPs online training

    Pricing and Market Access of ATMPs

    TBC, live online training


    This unique training focuses on the challenges and opportunities for the commercialisation of Advanced Therapy Medicinal Products (ATMPs), including autologous and allogeneic gene therapies, tissue-engineered products and somatic cell therapies, with the objective of speeding up patient access to innovations that have the potential to address high unmet needs in complex, chronic conditions for broad, heterogeneous populations, including paediatric patients.

    Who should attend?

    Value, pricing and market access executives, Marketing and commercial leaders, Medical affairs executives, ATMP clinical, regulatory, quality/CMC managers, Patient engagement, Patient-reported outcomes experts, Epidemiologists, Outcomes researchers, Health economists, Real-world evidence strategists, Digital health innovators and leaders

    Learning Objectives

    • Discuss strategies for ATMP pricing and innovative value-based contracting (risk sharing)
    • Explore the opportunities of real-world evidence for ATMP value demonstration
    • Consider payer uncertainties and strategize how to address these barriers to access
    • Gain insight into full-spectrum value evidence generation through the timely integration of market access strategy with clinical development and regulatory affairs
    • Discover the crucial role of patient engagement throughout the ATMP lifecycle
    • Analyse current ATMP successes and failures and create learnings for the next 3-5 years

    Key Topics

    • An Introduction to Advanced Therapy Medicinal Products (ATMPs)
    • Learning from cell and gene therapy market access successes and failures
    • Addressing payer uncertainties with early approvals and fewer clinical data
    • Demonstrating ATMP value with an innovative evidence generation strategy
    • Pricing potential cures: adapting reimbursement and value frameworks
    • Accelerating access by leveraging patient engagement and real-world evidence

    Our online training experience includes

    • Live interactive format via the Zoom platform
    • Access to the client zone with all training materials
    • Direct interaction with the trainer
    • Q&As, case studies, polls
    • Revisit recorded sessions for 30 days


    David Schwicker has biopharmaceutical consulting expertise spanning more than 25 years. Founder of ORPHA Strategy Consulting, and former Vice President with PAREXEL International in the United States. David is a sought-after expert for accelerating marketing authorization, time to launch, early patient and market access of ATMPs.
    Pricing and Market Access of ATMPs program agenda

    Pricing and Market Access of ATMPs

    Download the full training agenda to reveal complete session details, training takeaways, case studies, daily schedule, special features and full trainer bio.

    Online Training
    1 650  Price incl. VAT: 1 650 
    Equivalent of approx. 1 847 USD.
    The price calculation in USD is informative and might slightly differ from your bank exchange rate

    Price per delegate includes:

    Online participation

    Online workbook & materials

    Certificate of attendance

    Revisit recorded sessions for 30 days

    PC, microphone, camera, stable internet connection and the Zoom application.

    Yes, we will make every effort to ensure best possible interaction. You will see the slides, interact with the trainer and fellow participants. Questions and group exercises will be facilitated through the online meeting platform.

    Yes, you can transfer the registration to a colleague at any time.

    Yes, you may transfer your registration to a different event up to one month before the scheduled dates, provided the training fee has been paid in full.

    pharma learning leader

    Lydia Makori
    +421 222 200 543

    Training Details
    What participants said about this course

    "David (the trainer) is extremely knowledgable, it was a real pleasure to exchange with him."
    Pricing Director, Novo Nordisk

    "Case studies, the presentations, Q&A and also the music during the breaks."
    Senior Pricing & Market Access Manager, Vertex Pharmaceuticals

    "I enjoyed pricing strategies section - main interest. Also helpful to hear challenges/perspectives from other attendees."
    Global Commercial Pricing Manager, Cytiva Europe

    "Insights from real case scenarios and specific business cases."
    Market Access Director, PTC Therapeutics